Catalase down-regulation in cancer cells exposed to arsenic trioxide is involved in their increased sensitivity to a pro-oxidant treatment
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Catalase down-regulation in cancer cells exposed to arsenic trioxide is involved in their increased sensitivity to a pro-oxidant treatment
Authors
Keywords
Catalase, Arsenic trioxide, Pro-oxidant therapy, Breast cancer cells
Journal
Cancer Cell International
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-02-20
DOI
10.1186/s12935-018-0524-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High-dose ascorbate and arsenic trioxide selectively kill acute myeloid leukemia and acute promyelocytic leukemia blasts in vitro
- (2017) Nélida I. Noguera et al. Oncotarget
- SIRT2 Deacetylates and Inhibits the Peroxidase Activity of Peroxiredoxin-1 to Sensitize Breast Cancer Cells to Oxidant Stress-Inducing Agents
- (2016) Warren Fiskus et al. CANCER RESEARCH
- Chromatin remodeling regulates catalase expression during cancer cells adaptation to chronic oxidative stress
- (2016) Christophe Glorieux et al. FREE RADICAL BIOLOGY AND MEDICINE
- Overexpression of NAD(P)H:quinone oxidoreductase 1 (NQO1) and genomic gain of the NQO1 locus modulates breast cancer cell sensitivity to quinones
- (2016) Christophe Glorieux et al. LIFE SCIENCES
- Melatonin enhances arsenic trioxide-induced cell death via sustained upregulation of Redd1 expression in breast cancer cells
- (2016) Sun-Mi Yun et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Regulation of catalase expression in healthy and cancerous cells
- (2015) Christophe Glorieux et al. FREE RADICAL BIOLOGY AND MEDICINE
- Catalase expression in MCF-7 breast cancer cells is mainly controlled by PI3K/Akt/mTor signaling pathway
- (2014) Christophe Glorieux et al. BIOCHEMICAL PHARMACOLOGY
- Targeting Catalase but Not Peroxiredoxins Enhances Arsenic Trioxide-Induced Apoptosis in K562 Cells
- (2014) Li-Li Song et al. PLoS One
- Metabolism of arsenic and its toxicological relevance
- (2012) Takayuki Watanabe et al. ARCHIVES OF TOXICOLOGY
- Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy
- (2012) E. Chendamarai et al. BLOOD
- ATRA plus arsenic gets another "A" in APL
- (2012) J. H. Park BLOOD
- All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)
- (2012) H. J. Iland et al. BLOOD
- The arsenic-based cure of acute promyelocytic leukemia promotes cytoplasmic sequestration of PML and PML/RARA through inhibition of PML body recycling
- (2012) E. Lang et al. BLOOD
- Overexpression of GRP94 in breast cancer cells resistant to oxidative stress promotes high levels of cancer cell proliferation and migration: Implications for tumor recurrence
- (2012) Nicolas Dejeans et al. FREE RADICAL BIOLOGY AND MEDICINE
- Catalase overexpression in mammary cancer cells leads to a less aggressive phenotype and an altered response to chemotherapy
- (2011) Christophe Glorieux et al. BIOCHEMICAL PHARMACOLOGY
- Arsenic trioxide induces apoptosis of p53 null osteosarcoma MG63 cells through the inhibition of catalase
- (2011) Yang Wang et al. MEDICAL ONCOLOGY
- Arsenic trioxide — An old drug rediscovered
- (2010) Ashkan Emadi et al. BLOOD REVIEWS
- Ascorbate/menadione-induced oxidative stress kills cancer cells that express normal or mutated forms of the oncogenic protein Bcr-Abl. An in vitro and in vivo mechanistic study
- (2010) Raphaël Beck et al. INVESTIGATIONAL NEW DRUGS
- Arsenic Trioxide Controls the Fate of the PML-RAR Oncoprotein by Directly Binding PML
- (2010) X. W. Zhang et al. SCIENCE
- Molecular Distinctions between Stasis and Telomere Attrition Senescence Barriers Shown by Long-term Culture of Normal Human Mammary Epithelial Cells
- (2009) J. C. Garbe et al. CANCER RESEARCH
- In Situ Modulation of Oxidative Stress: A Novel and Efficient Strategy to Kill Cancer Cells
- (2009) J. Verrax et al. CURRENT MEDICINAL CHEMISTRY
- Catalase activity and arsenic sensitivity in acute leukemia
- (2008) Emma Coe et al. LEUKEMIA & LYMPHOMA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started